QHSLab Q1 revenue up 32% to $645K; gross margin expands to 66.6%

QHSLab, Inc.

2025-Q1 EPS reported -$0.01 revenue$645,419

Total revenue $645,419 vs $488,587 in Q1 2024, a 32.1% increase.
Gross margin improved to 66.6% from 58.6% on favorable product mix.
ISP revenue rose 28% to $162,502; Allergy Diagnostics up 11.7% to $264,913.
New clinical study performance obligations contributed $89,100 in revenue.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.